Walleye Trading’s Guardant Health GH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $7.01M | Sell |
46,700
-23,900
| -34% | -$2.6M | 0.01% | 1115 |
|
|
2026
Q1 | $6.52M | Sell |
70,600
-71,300
| -50% | -$7.16M | 0.01% | 993 |
|
|
2025
Q4 | $14.5M | Sell |
141,900
-32,100
| -18% | -$2.87M | 0.02% | 749 |
|
|
2025
Q3 | $10.9M | Buy |
174,000
+128,100
| +279% | +$6.97M | 0.02% | 854 |
|
|
2025
Q2 | $2.39M | Buy |
45,900
+36,000
| +364% | +$1.61M | ﹤0.01% | 1628 |
|
|
2025
Q1 | $422K | Buy |
9,900
+3,800
| +62% | +$164K | ﹤0.01% | 2629 |
|
|
2024
Q4 | $186K | Buy |
6,100
+4,900
| +408% | +$138K | ﹤0.01% | 3269 |
|
|
2024
Q3 | $27.5K | Sell |
1,200
-5,000
| -81% | -$142K | ﹤0.01% | 3626 |
|
|
2024
Q2 | $179K | Buy |
+6,200
| New | +$144K | ﹤0.01% | 3149 |
|
|
2024
Q1 | – | Sell |
-7,900
| Closed | -$214K | – | 4980 |
|
|
2023
Q4 | $214K | Sell |
7,900
-800
| -9% | -$21K | ﹤0.01% | 3736 |
|
|
2023
Q3 | $258K | Sell |
8,700
-3,700
| -30% | -$130K | ﹤0.01% | 3447 |
|
|
2023
Q2 | $444K | Sell |
12,400
-156,800
| -93% | -$4.5M | ﹤0.01% | 2843 |
|
|
2023
Q1 | $3.97M | Buy |
169,200
+140,000
| +479% | +$4M | 0.01% | 1203 |
|
|
2022
Q4 | $794K | Sell |
29,200
-23,900
| -45% | -$1.09M | ﹤0.01% | 2426 |
|
|
2022
Q3 | $2.86M | Sell |
53,100
-88,800
| -63% | -$4.56M | 0.01% | 1426 |
|
|
2022
Q2 | $5.72M | Buy |
141,900
+122,300
| +624% | +$6.06M | 0.02% | 937 |
|
|
2022
Q1 | $1.3M | Sell |
19,600
-16,500
| -46% | -$1.13M | ﹤0.01% | 2007 |
|
|
2021
Q4 | $3.61M | Buy |
36,100
+1,600
| +5% | +$165K | 0.01% | 1189 |
|
|
2021
Q3 | $4.31M | Sell |
34,500
-4,900
| -12% | -$582K | 0.02% | 1019 |
|
|
2021
Q2 | $4.89M | Sell |
39,400
-16,500
| -30% | -$2.22M | 0.02% | 807 |
|
|
2021
Q1 | $8.53M | Buy |
55,900
+42,400
| +314% | +$6.41M | 0.04% | 393 |
|
|
2020
Q4 | $1.74M | Sell |
13,500
-13,600
| -50% | -$1.56M | 0.01% | 1492 |
|
|
2020
Q3 | $3.03M | Buy |
27,100
+17,100
| +171% | +$1.56M | 0.02% | 859 |
|
|
2020
Q2 | $811K | Buy |
10,000
+5,100
| +104% | +$411K | 0.01% | 1851 |
|
|
2020
Q1 | $341K | Sell |
4,900
-32,000
| -87% | -$2.46M | ﹤0.01% | 2187 |
|
|
2019
Q4 | $2.88M | Buy |
36,900
+30,300
| +459% | +$2.18M | 0.02% | 938 |
|
|
2019
Q3 | $421K | Buy |
6,600
+700
| +12% | +$61.7K | ﹤0.01% | 2306 |
|
|
2019
Q2 | $509K | Buy |
+5,900
| New | +$451K | ﹤0.01% | 2174 |
|
Other funds holding GH
DTC
Walleye Trading's GH Position: Q1 2025 in Review
Walleye Trading sold out of Guardant Health (GH) in Q1 2025, closing a stake of 1,600 shares — an estimated $69K sold.
Walleye Trading first reported a position in GH in Q2 2020 and held it in 11 quarters. The position peaked at $2.72M in Q1 2021. 342 funds tracked by Wall St. Rank hold GH as of Q1 2025.
- Walleye Trading reported no remaining Guardant Health position as of Q1 2025 after selling out during the quarter.
- Walleye Trading sold 1,600 Guardant Health shares in Q1 2025, an estimated $69K.
- Walleye Trading first reported a position in Guardant Health in Q2 2020 and held it in 11 quarters.
- Walleye Trading's Guardant Health position peaked at $2.72M in Q1 2021.
- 342 funds tracked by Wall St. Rank held Guardant Health as of Q1 2025.
Based on Walleye Trading's 13F filing for Q1 2025, filed 14 May 2025.